Proxy Statement Details Major Litigation Progress and Significant Loan Recovery
Summary
Advanced Flower Capital Inc. filed its definitive proxy statement, revealing that legal actions against a borrower with a $78.8 million outstanding loan are advancing, with motions to dismiss denied. Separately, the company recovered $6.2 million in Q1 2026 from another distressed loan.
Key Events
-
Legal Actions Advance on $78.8M Distressed Loan
The New York state Court denied a motion to dismiss in the case against the parent of Subsidiary of Private Company G on March 17, 2026. Additionally, on March 31, 2026, the Southern District of New York denied motions to transfer and to dismiss fraud claims against the guarantors, allowing the action to proceed to discovery. These developments relate to a loan with an outstanding principal of approximately $78.8 million as of December 31, 2025, where the company is pursuing foreclosure and claims including breach of guaranty and fraud.
-
Significant Recovery on Private Company A Loan
During the first quarter of 2026, the company received approximately $6.2 million in loan payments from Private Company A, reducing the outstanding principal balance to $40.6 million as of March 31, 2026. This follows the loan being placed on non-accrual status in March 2024.
-
Annual Shareholder Meeting Scheduled
The company will hold its Annual Meeting of Shareholders virtually on Thursday, May 28, 2026, to elect two Class III directors and ratify the appointment of CohnReznick LLP as its independent registered public accounting firm for 2026.
Analysis
This definitive proxy statement, while primarily a routine governance filing, contains critical updates regarding the company's distressed loan portfolio and related legal actions. The denial of motions to dismiss in the lawsuit against Subsidiary of Private Company G and its guarantors, involving an outstanding principal of $78.8 million, indicates that the company's claims are proceeding, which is a positive procedural development for potential recovery. Concurrently, the company reported a significant $6.2 million recovery in Q1 2026 from another distressed loan (Private Company A), reducing its balance to $40.6 million. These financial and legal developments are highly material for a company that reported a substantial net loss in 2025, directly impacting its credit quality and future financial health. Investors should monitor the outcomes of these legal proceedings and further loan recoveries.
At the time of this filing, AFCG was trading at $2.70 on NASDAQ in the Unknown sector, with a market capitalization of approximately $63.5M. The 52-week trading range was $2.06 to $5.87. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.